Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
STLN

Starling Oncology (STLN) stock: insider trades, news & valuation

Health Care · Net buying
Close · Oct 9, 2026 $6.63 +7.3% on the day +69.6% over 12 months 52-week range $2.38 – $7.05

Share price and insider trades

STLN closeInsider buyInsider sale
2468NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $879 on 2026-01-02 · Robert Ross CarterSold $50,265 on 2025-12-15 · Brad HivelyBought $57,000 on 2026-06-04 · Jorey ChernettBought $62,000 on 2026-04-09 · Jorey ChernettBought $78,480 on 2026-08-14 · Jorey ChernettBought $81,190 on 2026-03-27 · Jorey ChernettBought $83,750 on 2026-03-20 · Jorey ChernettBought $87,750 on 2026-07-10 · Jorey ChernettBought $90,360 on 2026-06-23 · Jorey ChernettBought $94,860 on 2026-07-21 · Jorey ChernettSold $126,166 on 2026-06-08 · Yale PodnosSold $134,516 on 2026-04-16 · Mohit KaushalBought $136,345 on 2026-05-20 · Jorey ChernettBought $142,950 on 2026-05-19 · Jorey ChernettSold $150,358 on 2026-07-14 · Yale PodnosBought $157,500 on 2026-03-26 · Jorey ChernettSold $200,000 on 2025-11-18 · Mark L PacalaSold $200,501 on 2026-04-14 · Mohit KaushalBought $200,641 on 2026-03-16 · Jorey ChernettBought $256,500 on 2026-03-17 · Jorey ChernettBought $388,750 on 2026-03-24 · Jorey ChernettBought $767,960 on 2026-03-13 · Jorey ChernettSold $1,945,533 on 2026-08-21 · Brad Hively
Bought, 12 months$2.7M
Sold, 12 months$2.8M
Insiders buying1
Insiders selling5

Starling Oncology insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $2.7M and 5 sold $2.8M of STLN stock on the open market.

STLN insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $250K sold (4 trades)Q4 2025Q1 2026: $1.9M bought (7 trades)$1.9MQ1 2026: $879 sold (1 trades)Q1 2026Q2 2026: $489K bought (6 trades)$489KQ2 2026: $461K sold (3 trades)Q2 2026Q3 2026: $261K bought (3 trades)$261KQ3 2026: $2.1M sold (3 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$261K3$2.1M3
Q2 2026$489K6$461K3
Q1 2026$1.9M7$8791
Q4 2025—0$250K4

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$676MMedical Care Facilities
Profit margin-6.2%Revenue growth +34.6%
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit+$2.6MOn all tracked purchases +95.0%

Summary

Over the past 12 months, 1 Starling Oncology, Inc. insider reported open-market purchases totaling $2.7M, while 5 insiders reported sales totaling $2.8M. Among insiders with enough purchase history to measure, Jorey Chernett (10% Owner) has the highest Insider Score at 100. 6 of 11 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

STLN stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 24SEC Brad HivelyDirector Sell Plan 298,853411,976 held (−42%) $6.51 $1.9M +1.8% —
Aug 17SEC Jorey Chernett10% Owner Buy 12,00010,660,858 held (+0%) $6.54 $78K +1.4% 100
Jul 22SEC Jorey Chernett10% Owner Buy 18,00010,648,858 held (+0%) $5.27 $95K +25.8% 100
Jul 16SEC Yale PodnosChief Medical Officer Sell Plan 17,974259,527 held (−6%) $6.43 $116K +3.1% —
Jul 16SEC Yale PodnosChief Medical Officer Sell Plan 5,478259,527 held (−2%) $6.35 $35K +4.4% —
Jul 13SEC Jorey Chernett10% Owner Buy 15,00010,630,858 held (+0%) $5.85 $88K +13.3% 100
Jun 24SEC Jorey Chernett10% Owner Buy 18,00010,615,858 held (+0%) $5.02 $90K +32.1% 100
Jun 9SEC Yale PodnosChief Medical Officer Sell Plan 23,451259,527 held (−8%) $5.38 $126K +23.2% —
Jun 5SEC Jorey Chernett10% Owner Buy 12,00010,579,858 held (+0%) $4.75 $57K +39.6% 100
May 21SEC Jorey Chernett10% Owner Buy 33,50010,567,858 held (+0%) $4.07 $136K +62.9% 100
May 21SEC Jorey Chernett10% Owner Buy 5,00010,534,358 held (+0%) $4.05 $20K +63.7% 100
May 20SEC Jorey Chernett10% Owner Buy 30,00010,529,358 held (+0%) $4.09 $123K +62.1% 100
Apr 16SEC Mohit KaushalDirector Sell Plan 57,286211,016 held (−21%) $3.50 $201K +89.4% —
Apr 16SEC Mohit KaushalDirector Sell Plan 38,433172,583 held (−18%) $3.50 $135K +89.4% —
Apr 13SEC Jorey Chernett10% Owner Buy 20,00010,499,358 held (+0%) $3.10 $62K +113.9% 100
Mar 30SEC Jorey Chernett10% Owner Buy 27,42910,479,358 held (+0%) $2.96 $81K +124.0% 100
Mar 27SEC Jorey Chernett10% Owner Buy 50,00010,451,929 held (+0%) $3.15 $158K +110.5% 100
Mar 25SEC Jorey Chernett10% Owner Buy 125,00010,401,929 held (+1%) $3.11 $389K +113.2% 100
Mar 23SEC Jorey Chernett10% Owner Buy 25,00010,276,929 held (+0%) $3.35 $84K +97.9% 100
Mar 17SEC Jorey Chernett10% Owner Buy 263,00010,115,944 held (+3%) $2.92 $768K +127.1% 100
Mar 17SEC Jorey Chernett10% Owner Buy 75,00010,251,929 held (+1%) $3.42 $256K +93.9% 100
Mar 17SEC Jorey Chernett10% Owner Buy 60,98510,176,929 held (+1%) $3.29 $201K +101.5% 100
Jan 5SEC Robert Ross CarterCFO Sell 247235,122 held (−0%) $3.56 $879 +86.2% —
Dec 16SEC Brad HivelyDirector Sell 13,333683,721 held (−2%) $3.77 $50K +75.9% —
Nov 20SEC Mark L PacalaDirector Sell 46,630174,971 held (−21%) $4.00 $187K +65.8% —
Nov 20SEC Mark L PacalaDirector Sell 2,160222,811 held (−1%) $4.00 $9K +65.8% —
Nov 20SEC Mark L PacalaDirector Sell 1,210221,601 held (−1%) $4.00 $5K +65.8% —

Insiders at Starling Oncology, Inc.

InsiderBoughtSoldLast filingScore
Jorey Chernett10% Owner $2.7M — Aug 17, 2026 100
Brad HivelyDirector — $2.0M Aug 24, 2026 —
Mohit KaushalDirector — $335K Apr 16, 2026 —
Yale PodnosChief Medical Officer — $277K Jul 16, 2026 —
Mark L PacalaDirector — $200K Nov 20, 2025 —
Robert Ross CarterCFO — $879 Jan 5, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

STLN stock: common questions

Are Starling Oncology, Inc. insiders buying STLN stock?

In the past 12 months, 1 insiders reported open-market purchases of STLN worth $2.7M. The latest was 10% Owner Jorey Chernett bought $78K of STLN at $6.54.

Are Starling Oncology, Inc. insiders selling STLN stock?

5 insiders reported sales worth $2.8M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is STLN's 52-week range?

Over the past year STLN has traded between $2.38 and $7.05. It last closed at $6.63 on Oct 9, 2026.